参考文献/References:
[1] 汤美雯.再生障碍性贫血机制的研究进展[J].医学前沿,2012,2(17):101-102.
[2] Zheng ZY,Yu XL,Dai TY,et al.Panaxdiol saponins component promotes hematopoiesis and modulates T lymphocyte dysregulation in aplastic anemia model mice[J].Chin J Integr Med,2019,25(12):902-910.
[3] 曹宇峰,张琳琳,吕丽丽,等.健脾补肾方对再生障碍性贫血患者免疫T细胞亚群及相关细胞因子的影响[J].河北医药,2020,42(4):508-511,516.
[4] 贺 欣,王化泉,邵宗鸿.Tim3和BAT3在再生障碍性贫血中免疫机制的研究进展[J].中国免疫学杂志,2020,36(5):630-633.
[5] Zeng W,Miyazawa A,Chen G,et al.Interferon gamma-induced gene expression in CD34 cells:Identification of pathologic cytokine-specific signature profiles[J].Blood,2006,107(1):167-175.
[6] 张 震.辨证论治新理念与临床应用[M].上海:上海科学技术出版社,2014:86-89.
[7] 邢海燕,胡春萍,蔡雪婷,等.再生障碍性贫血小鼠造模方法[J].中国老年医学杂志,2013,15(23):5888-5890.
[8] 黄继汉,黄晓晖,陈志扬,等.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072.
[9] 姚 军,李树浓.淋巴细胞与再生障碍性贫血关系的实验研究[J].中华血液学杂志,1991,12(5):229-231.
[10] 张宇辰.针对不同发病机制建立再生障碍性贫血动物模型的研究概况[J].中国实验血液学杂志,2015,23(1):285-289.
[11] 李 锐,陈文娜,范梦天.苯诱发再生障碍性贫血小鼠模型建立[J].中国公共卫生,2010,26(6):738-739.
[12] 赵 琳,肖 燕,金润铭.再生障碍性贫血发病机制研究进展[J].中国实用儿科杂志,2011,26(7):545-548.
[13] Faiola B,Bauer AK,Fuller ES,et al.Variations in Prkdc and Sus-ceptibility to benzene-induced toxi city in mice[J].Toxicol Sci,2003,75(2):321-332.
[14] Zhang HX,Wu GS,Guo WL.Changes and significances of Th1/Th2,related cytokines and T cell subgroup in aplastic anemia patients[J].J Hainan Med University,2016,22(10):778-782.
[15] 谌海燕,郭 明,刘军霞,等.艾灸膈俞穴对重型再生障碍性贫血模型小鼠免疫调控的影响[J].中华中医药学刊,2019,37(7):1789-1792.
[16] Krause DS,Fackler JM,Civic SI,et al.CD34:Structure,biology and clinical utility[J].Blood,1996,87(1):1-13.
[17] 于天祥.基于IFN-γ/T-bet、IL-4/STAT6信号通路探讨再生障碍性贫血发病机制及补肾健脾祛障方的干预作用[D].济南:山东中医药大学,2017.
[18] 黄莉荣,薛 征.基于Th1/Th2失衡探讨再生障碍性贫血中西医治疗研究进展[J].陕西中医,2021,42(11):1644-1647.
[19] Qiao XH,Xie XT,Shi W,et al.OCH-mediated shift of Th1 and Th2 cytokines by NKT cells in mice with aplastic anemia[J].Medical Oncology(Northwood,London,England),2015,32(3):67.
[20] Mingueneau M,Roncagalli R,Gregoire C,et al.Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor[J].Immunity,2009,31(2):197-208.
[21] 李 芮,刘 健,靳 楠,等.基于网络药理学探讨当归补血汤治疗再生障碍性贫血作用机制[J].陕西中医,2022,43(3):384-389.
相似文献/References:
[1]唐洪屈,刘 娜△,刘 勇,等.从脾肾论治熟地黄在慢性再生障碍性贫血治疗中的应用*[J].陕西中医,2020,(6):780.[doi:DOI:10.3969/j.issn.10007369.2020.06.022]
[2]黄莉荣,薛 征.基于Th1/Th2失衡探讨再生障碍性贫血中西医治疗研究进展[J].陕西中医,2021,(11):1644.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.034]
HUANG Lirong,XUE Zheng.Discussion on treatment progress of traditional Chinese and western medicine of aplastic anemia based on Th1/Th2[J].,2021,(8):1644.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.034]
[3]李 芮,刘 健,靳 楠,等.基于网络药理学探讨当归补血汤治疗再生障碍性贫血作用机制[J].陕西中医,2022,(3):384.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.028]
[4]何昊兰,鲁英娟,张小莉,等.健脾生血汤联合促红素治疗再生障碍性贫血疗效及对患者中医症候、炎症因子水平的影响[J].陕西中医,2022,(10):1411.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.021]
HE Haolan,LU Yingjuan,ZHANG Xiaoli,et al.Effect of Jianpi Shengxue decoction combined with erythropoietin on aplastic anemia and its effect on TCM symptoms and inflammatory factors[J].,2022,(8):1411.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.021]
[5]李玎玎,何丹迪,王金环.基于“虫子学说”探讨中医药对再生障碍性贫血免疫调控的研究进展[J].陕西中医,2025,46(8):1136.[doi:DOI:10.3969/j.issn.1000-7369.2025.08.026]
LI Dingding,HE Dandi,WANG Jinhuan.Exploring the research progress of traditional Chinese medicine on immune regulation of aplastic anemia from insect theories[J].,2025,46(8):1136.[doi:DOI:10.3969/j.issn.1000-7369.2025.08.026]
[6]袁艺心,李柯馨,叶苗青,等.基于“补肝体强肝用”思想探讨长安张氏肝病流派辨治再生障碍性贫血[J].陕西中医,2026,(1):77.[doi:DOI:10.3969/j.issn.1000-7369.2026.01.013]
YUAN Yixin,LI Kexin,YE Miaoqing,et al.Discussion on the treatment of aplastic anaemia by Chang’an ZHANG’s liver disease school based on the idea of “nourishing the liver’s substance and strengthening the liver’s function”[J].,2026,(8):77.[doi:DOI:10.3969/j.issn.1000-7369.2026.01.013]